S&P Capital IQ

S&P Capital IQ is a leading provider of multi-asset class data, research, and analytics to institutional investors, investment banks, and corporations worldwide. While not a life sciences company itself, it provides critical financial intelligence and sector-specific research used by biotech and pharmaceutical analysts to track industry trends, M&A activity, and company valuations. The platform offers comprehensive data on public and private companies, including detailed financial statements, equity research, and market pricing. It currently operates as a key component of S&P Global Market Intelligence, following the merger of S&P Capital IQ and SNL Financial. The service is essential for financial decision-making and strategic planning within the healthcare and broader corporate sectors.